E&C Health Subcommittee To Hold Hearing With Top FDA Officials

The House Energy & Commerce health subcommittee plans to hold a hearing May 22 on FDA’s regulation of drugs, biologics and devices featuring the agency’s lead regulators in all three areas, the committee announced Monday (May 6). The hearing will include testimony from FDA’s drug center director Patrizia Cavazzoni, biologics center director Peter Marks and device center director Jeff Shuren. “America remains the leader in developing cutting edge biomedical innovation. Countries around the globe look to the FDA for guidance...